This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Locasciulli A, Testa M, Velsecchi MG, Vecchi L, Longoni D, Sparano P, Rovelli A, Uderzo C, Masera G, Alberti A . Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study Blood 1997 90: 3799–3805
Pariente EA, Goudeau A, Dubois F, Degott C, Gluckman E, Devergie A, Berchot C, Schenmetzler C, Bernuau J . Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation Dig Dis Sci 1988 33: 1185–1191
McIvor C, Morton J, Bryant A, Cooksley WG, Durrant S, Walker N . Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation Ann Int Med 1994 121: 274–275
Miura Y, Takamatsu H, Okumura H, Yoshida T, Nakao S, Matsuda T . Allogeneic bone marrow transplantation for a patient complicated by chronic hepatitis due to precore mutant hepatitis B virus: failure of management with interferon-α therapy Am J Hematol 1997 54: 344–345
Kikuchi A, Ohashi H, Hanada R, Yamamoto K . Low-dose cytarabine (AraC) + recombinant human granulocyte colony-stimulating factor (rhG-CSF) for myelodysplastic syndrome (MDS) Leukemia 1999 13: 980–981
Reed EC, Myerson D, Corey L, Myers JD . Allogeneic bone marrow transplantation in patients positive for hepatitis B surface antigen Blood 1990 77: 195–200
Lau GKK, Liang R, Chiu EK, Lee CK, Lam SK . Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study Bone Marrow Transplant 1997 19: 795–799
Junker-Niepmann M, Bartenschalager R, Shaller H . A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA EMBO 1990 9: 3389–3396
Lau GK, Lok AS, Liang RH, Lai CL, Chiu EK, Lau YL, Lam SK . Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer Hepatology 1997 25: 1497–1501
Ito S, Nakazono K, Murasawa A, Mita Y, Hata K, Saito N, Kikuchi M, Yoshida K, Nakano M, Gejyo F . Development of fluminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient Arthritis Rheum 2001 44: 339–342
Dai MS, Lu JJ, Chen YC, Perng CL, Chao TY . Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients Cancer 2001 92: 2927–2932
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kikuchi, A., Kagimoto, S., Kishimoto, H. et al. Allogeneic bone marrow transplantation (BMT) in a patient with myelodysplastic syndrome (MDS) infected by hepatitis B virus (HBV) precore mutant: favorable outcome with slow tapering of immunosuppressive agents. Leukemia 16, 2333–2335 (2002). https://doi.org/10.1038/sj.leu.2402649
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402649